Android App
About SPORTIVO Network
0 Комментарии
0 Поделились
2Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Global Doripenem Market to Reach USD 680 Million by 2034 Amid Rising Antibiotic Resistance and Hospital-Acquired InfectionsAccording to a new report from Intel Market Research, the global Doripenem market was valued at USD 450 million in 2024 and is projected to reach USD 680 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2025–2034). This growth stems from escalating antibiotic resistance and increasing prevalence of hospital-acquired infections requiring last-resort...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Ceftazidime Avibactam Market Growth & CAGR 9.7% ForecastAccording to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Комментарии 0 Поделились 690 Просмотры 0 предпросмотр
-
Ceftazidime Avibactam Market Growth & CAGR 9.7% ForecastAccording to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Комментарии 0 Поделились 698 Просмотры 0 предпросмотр
-
Global Ataxia Market Strategic Analysis and Industry ForecastThe Global Ataxia Market Size Was Valued at USD 23.12 Billion in 2023 and is Projected to Reach USD 37.43 Billion by 2032, Growing at a CAGR of 5.50% From 2024-2032. Ataxia is a neurological sign consisting of a lack of voluntary coordination of muscle movements that can include gait abnormality, speech changes, and abnormalities in eye movements. The ataxia market focuses on the development...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Global Ceftazidime Avibactam Market Insights & Growth Trends | CAGR 9.7% (2026–2034)According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Комментарии 0 Поделились 972 Просмотры 0 предпросмотр
-
Global Ceftazidime Avibactam Market Insights & Growth Trends | CAGR 9.7% (2026–2034)According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Комментарии 0 Поделились 989 Просмотры 0 предпросмотр
-
Global Multiple Drug Resistance Bacterial Infection Treatment Market Share Analysis by Geography – Industry Forecast to 2031The global Multiple Drug Resistance Bacterial Infection Treatment Market is becoming increasingly vital as the incidence of antimicrobial resistance (AMR) escalates across the world. Multidrug‑resistant (MDR) bacterial infections represent a critical public health threat, with resistant pathogens such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii reducing the...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Global Neomycin Market Set to Reach USD 620 Million by 2034 Amid Rising Infection BurdenAccording to a new report from Intel Market Research, the global Neomycin market was valued at USD 420 million in 2025 and is projected to reach USD 620 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2026–2034). This growth is fueled by rising antibiotic demand in human healthcare and veterinary medicine, coupled with increasing prevalence of bacterial...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Hospital-Acquired Disease Testing Market to Reach USD 724 Million by 2031 | CAGR 5.6%According to a newly published market research report by 24LifeSciences, global hospital-acquired disease testing market was valued at USD 498 million in 2024 and is projected to reach USD 724 million by 2031, growing at a compound annual growth rate (CAGR) of 5.6% during the forecast period 2026–2034. Hospital-acquired infections (HAIs), clinically significant as nosocomial...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Systemic Infection Treatment Market to Reach USD 22.1 Billion by 2031 | CAGR 6.4%According to a newly published market research report by 24LifeSciences, global systemic infection treatment market was valued at USD 14.3 billion in 2024 and is projected to reach USD 22.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2031. Systemic infection treatments combat infections that have spread throughout the bloodstream...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Systemic Infection Treatment Market to Reach USD 22.1 Billion by 2031 | CAGR 6.4%According to a newly published market research report by 24LifeSciences, global systemic infection treatment market was valued at USD 14.3 billion in 2024 and is projected to reach USD 22.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2031. Systemic infection treatments combat infections that have spread throughout the bloodstream...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
Расширенные страницы
Czech
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek